Bellevue Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,085,600
Closed -$108M 233
2019
Q3
$108M Sell
1,085,600
-764,400
-41% -$72.6M 2% 13
2019
Q2
$171M Buy
1,850,000
+1,832,212
+10,300% +$174M 2.92% 8
2019
Q1
$1.68M Sell
17,788
-639,813
-97% -$56M 0.09% 116
2018
Q4
$42.1M Buy
657,601
+51,601
+9% +$3.81M 2.77% 9
2018
Q3
$54.2M Buy
606,000
+73,200
+14% +$6.47M 3.44% 4
2018
Q2
$42.3M Buy
532,800
+98,400
+23% +$8.17M 3.61% 3
2018
Q1
$38.8M Buy
434,400
+30,135
+7% +$2.89M 3.84% 3
2017
Q4
$42.2M Buy
404,265
+71,896
+22% +$8.11M 4.41% 1
2017
Q3
$48.5M Buy
332,369
+70,377
+27% +$9.59M 5.07% 1
2017
Q2
$34M Buy
261,992
+10,612
+4% +$1.3M 4.02% 1
2017
Q1
$31.3M Buy
251,380
+51,730
+26% +$6.19M 4.17% 1
2016
Q4
$23.1M Buy
199,650
+5,400
+3% +$601K 4.73% 1
2016
Q3
$20.3M Sell
194,250
-1,800
-0.9% -$195K 3.67% 3
2016
Q2
$19.3M Sell
196,050
-14,500
-7% -$1.5M 3.64% 3
2016
Q1
$21.1M Buy
+210,550
New +$21.7M 3.82% 2

Other funds holding CELG

Bellevue Group's CELG Position: Q4 2019 in Review

Bellevue Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,085,600 shares — an estimated $108M sold.

Bellevue Group first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $171M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bellevue Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bellevue Group sold 1,085,600 Celgene Corp shares in Q4 2019, an estimated $108M.
  • Bellevue Group first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Bellevue Group's Celgene Corp position peaked at $171M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bellevue Group's 13F filing for Q4 2019, filed 14 Feb 2020.